Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.

World journal of surgical oncology - 19 May 2014

Sun Yan, Yu Xinmin, Shi Xun, Hong Wei, Zhao Jun, Shi Lei

Abstract excerpt

BACKGROUND: A new lung adenocarcinoma classification proposed by the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society (IASLC/ATS/ERS) has recently been published. This study aimed to investigate the utility of the new histological classification for identifying the prognostic subtypes of adenocarcinomas in stage IB patients.Correlations between...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Papillary

Share to Combined Modality Therapy

Share to Lymphatic Metastasis

Share to Multivariate Analysis

Share to Neoplasm Staging

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 24885205
DOI: 10.1186/1477-7819-12-148
PMCID: PMC4067105

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.PMID 24885205Read ↗

Correlation of EGFR mutation and predominant histologic subtype according to the new lung adenocarcinoma classification in Chinese patients.Semantic proximity Read ↗

The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma.Semantic proximity Read ↗

Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.Semantic proximity Read ↗

Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.Semantic proximity Read ↗

The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.Semantic proximity Read ↗

The impact of postoperative adjuvant therapy on EGFR-mutated stage IA lung adenocarcinoma with micropapillary pathological subtypes.Semantic proximity Read ↗

Clinical usefulness of the 3-tier classification according to the proportion of morphological patterns for patients with pathological stage I invasive lung adenocarcinoma.Semantic proximity Read ↗

Association of IASLC/ATS/ERS Histologic Subtypes of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutations in 320 Resected Cases.Semantic proximity Read ↗

Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.Semantic proximity Read ↗

The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.Semantic proximity Read ↗

[Correlation between the new lung adenocarcinoma classification and epidermal growth factor receptor mutation].Semantic proximity Read ↗

The adjuvant chemotherapy can be omitted for lepidic predominant lung adenocarcinoma in stage IB of the 8th TNM staging system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.